ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

APH Alliance Pharma Plc

34.95
3.35 (10.60%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma Plc LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.35 10.60% 34.95 34.65 34.70 35.10 31.00 31.00 4,048,392 16:35:20
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 167.42M 936k 0.0017 204.12 187.43M

Alliance Pharma PLC Notification of Major Interest in Shares (6866B)

05/04/2017 1:30pm

UK Regulatory


TIDMAPH TIDMAV.

RNS Number : 6866B

Alliance Pharma PLC

05 April 2017

 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 
------------------------------------------------------------------------------------------------------------------------ 
 
 1. Identity of the issuer or the underlying                     Alliance Pharma plc 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: 
--------------------------------------------------------------  -------------------------------------------------------- 
 2 Reason for the notification (please tick the appropriate box or boxes): 
------------------------------------------------------------------------------------------------------------------------ 
 An acquisition or disposal of voting rights 
------------------------------------------------------------------  ---------------------------------------------------- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
------------------------------------------------------------------  ---------------------------------------------------- 
 An acquisition or disposal of instruments with similar economic 
  effect to qualifying financial instruments 
------------------------------------------------------------------  ---------------------------------------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------  ---------------------------------------------------- 
 
   Other (please specify): 
----------------------------------------------------------  ------  ---------------------------------------------------- 
 3. Full name of person(s) subject                             Aviva plc & its subsidiaries 
  to the 
  notification obligation: 
------------------------------------------------------------  ---------------------------------------------------------- 
 4. Full name of shareholder(s)                                     Registered Holder: 
  (if different from 3.): 
                                                                    Available on request 18,450* 
 
                                                                    Chase (GA Group) Nominees Limited 35,223,402* 
 
                                                                    *denotes direct interest 
 
                                                                    Chase Nominees Limited 1,165,093 
------------------------------------------------------------  ---------------------------------------------------------- 
 5. Date of the transaction and date                           3 April 2017 
  on 
  which the threshold is crossed 
  or 
  reached: 
------------------------------------------------------------  ---------------------------------------------------------- 
 6. Date on which issuer notified:                             5 April 2017 
------------------------------------------------------------  ---------------------------------------------------------- 
 7. Threshold(s) that is/are crossed                           8% to 7% Change at Direct Interest 
  or                                                            Level (Box 8A) 
  reached: 
------------------------------------------------------------  ---------------------------------------------------------- 
 
 
 
 8. Notified details: 
-------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares 
-------------------------------------------------------------------------------------------------------------- 
 Class/type      Situation previous           Resulting situation after the triggering 
 of               to the triggering            transaction 
 shares           transaction 
 
 if possible 
 using 
 the ISIN CODE 
--------------  ---------------------------  ----------------------------------------------------------------- 
                 Number         Number        Number          Number of voting            % of voting rights 
                  of             of            of shares       rights 
                  Shares         Voting 
                                 Rights 
--------------  -------------  ------------  --------------  --------------------------  --------------------- 
                                              Direct          Direct       Indirect       Direct    Indirect 
--------------  -------------  ------------  --------------  -----------  -------------  --------  ----------- 
 Ordinary 
  Shares 
 
  GB0031030819   43,574,295*    43,574,295*   36,406,945      35,241,852   1,165,093      7.46%     0.24% 
                -------------  ------------  --------------  -----------  -------------  --------  ----------- 
 
 
   * Includes Right to Recall Loaned Shares (108,293) 
-------------------------------------------------------------------------------------------------------------- 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------- 
 Type of         Expiration     Exercise/                     Number of voting            % of voting 
 financial        date           Conversion Period             rights that may             rights 
 instrument                                                    be 
                                                               acquired if the 
                                                               instrument is 
                                                               exercised/ converted. 
--------------  -------------  ----------------------------  --------------------------  --------------------- 
 RIGHT TO 
  RECALL                                                        50,000* 
  LOANED 
  SHARES         N/A            N/A                             *Direct Interest          0.01% 
--------------  -------------  ----------------------------  --------------------------  --------------------- 
 
 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments 
---------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------- 
 Type of financial   Exercise   Expiration   Exercise/     Number of voting     % of voting rights 
  instrument          price      date         Conversion    rights instrument 
                                              period        refers to 
------------------  ---------  -----------  ------------  -------------------  --------------------- 
                                                                                Nominal      Delta 
------------------  ---------  -----------  ------------  -------------------  -----------  -------- 
 
 
 
 Total (A+B+C) 
------------------------------------------------------ 
 Number of voting rights   Percentage of voting rights 
------------------------  ---------------------------- 
 36,456,945                7.71% 
------------------------  ---------------------------- 
 
 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: 
-------------------------------------------------------------------------------------------------------------- 
                                        The voting rights are managed and controlled by Aviva Investors Global 
                                        Services Limited and Friends Provident International Limited, with the 
                                                                  following chain of controlled undertakings:- 
 
                                                                      Aviva Investors Global Services Limited: 
                                                                               *    Aviva plc (Parent Company) 
 
 
                                                    *    Aviva Group Holdings Limited (wholly owned subsidiary 
                                                                                                 of Aviva plc) 
 
 
                                                           *    Aviva Investors Holdings Limited (wholly owned 
                                                                   subsidiary of Aviva Group Holdings Limited) 
 
 
                                                    *    Aviva Investors Global Services Limited (wholly owned 
                                                               subsidiary of Aviva Investors Holdings Limited) 
 
 
 
                                                                      Friends Provident International Limited: 
                                                                               *    Aviva plc (Parent Company) 
 
 
                                                    *    Aviva Group Holdings Limited (wholly owned subsidiary 
                                                                                                 of Aviva plc) 
 
 
                                                    *    Friends Provident International Limited (wholly owned 
                                                                   subsidiary of Aviva Group Holdings Limited) 
 
 Proxy Voting: 
-------------------------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder:                                  See Section 4 
-------------------------------------------------------------  ----------------------------------------------- 
 11. Number of voting rights proxy holder will 
  cease 
  to hold: 
-------------------------------------------------------------  ----------------------------------------------- 
 12. Date on which proxy holder will cease to 
  hold 
  voting rights: 
-------------------------------------------------------------  ----------------------------------------------- 
 
 
  13. Additional information:                                    Figures are based on a total number 
                                                                 of voting rights of 472,716,142, as 
                                                                 per the Company's 'Application for admission' 
                                                                 announcement of 14(th) February 2017. 
-------------------------------------------------------------  ----------------------------------------------- 
 14. Contact name:                                                  James Clark, Aviva plc 
-------------------------------------------------------------  ----------------------------------------------- 
 15. Contact telephone number:                                      01603 683853 
-------------------------------------------------------------  ----------------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEAALSEAFXEFF

(END) Dow Jones Newswires

April 05, 2017 08:30 ET (12:30 GMT)

1 Year Alliance Pharma Chart

1 Year Alliance Pharma Chart

1 Month Alliance Pharma Chart

1 Month Alliance Pharma Chart

Your Recent History

Delayed Upgrade Clock